ECOLAB INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 299.2 BRL | +4.32% |
|
+4.32% | +30.69% |
| 21/05 | UBS Adjusts Price Target on Ecolab to $270 From $269, Maintains Buy Rating | MT |
| 16/05 | Everlasting momentum |  |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 35.33 and 31.53 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 4.56 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +30.69% | 66.57B | - | ||
| +3.00% | 49.81B | A- | ||
| +22.01% | 42.77B | B+ | ||
| +22.79% | 26.3B | A- | ||
| +10.06% | 19.26B | C+ | ||
| -2.43% | 16.56B | B+ | ||
| +5.63% | 15.96B | B+ | ||
| -14.90% | 14.45B | C+ | ||
| -27.16% | 14.82B | A- | ||
| -19.26% | 13.89B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ECL Stock
- E1CL34 Stock
- Ratings Ecolab Inc.
